September 13-16, 2020

M. David Weingarten, Ph.D.

Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
David Weingarten

M. David Weingarten, Ph.D.

Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
linkedin-icon
404.653.6457
david.weingarten@finnegan.com

Biography

David Weingarten, Ph.D., has a diverse chemistry and life sciences practice focusing on patent litigation before U.S. district courts and the U.S. International Trade Commission (ITC), post-grant trial proceedings at the U.S. Patent and Trademark Office (USPTO), patent prosecution, and strategic portfolio management.

David’s practice focuses on complex chemical, pharmaceutical, and biotechnology patent litigation before U.S. district courts and the ITC and on post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the USPTO. David also has extensive experience preparing and prosecuting U.S. patent applications, coordinating and managing foreign prosecution, developing strategies for portfolio management and planning, and participating in diligence projects on behalf of domestic and foreign clients. In addition, he drafts opinions on patent infringement, validity, and enforceability, and prepares intellectual property agreements, such as those relating to license and supply.

David represents on a pro bono basis disabled veterans in proceedings before the U.S. Court of Appeals for Veterans Claims. He also serves as an industry mentor for students from Emory University and Georgia Institute of Technology to help prepare them for careers in technology innovation. David is recognized on the Capital Pro Bono High Honor Roll.

Prior to practicing law, David spent more than a decade in the pharmaceutical industry developing drugs across a wide range of therapeutic areas, including cardiovascular, metabolic, respiratory, and inflammation. As a member of senior management, he was responsible for leading research and development efforts in drug discovery, process research and development, and manufacturing. He also prepared New Drug Application (NDA) submissions, conducted due diligence, and managed technology transfers.

During his doctoral studies, David investigated the rhodium(II)-catalyzed reaction of a-diazo ketones and its application toward organic synthesis. As a National Institutes of Health (NIH) post-doctoral research fellow at Columbia University, he designed and developed new combinatorial methods for determining enantioselective chemical processes and implemented molecular modeling to analyze complex experimental results.

While at Emory University School of Law, David was a Robert W. Woodruff Fellow; a Dean’s teaching Fellow; received awards for outstanding academic achievement in contract drafting, negotiations, deal skills, and patents and global health; and was awarded first place, Emory University School of Law Transactional Negotiation Meet. David was also an Achievement Rewards for College Scientists (ARCS) scholar; a Northern Telecom Scholar; a Department of Education graduate fellow; and an American Chemical Society, Organic Division graduate fellow at Emory University.

All sessions by M. David Weingarten, Ph.D.